NMDA Receptor Subunit Expression and PAR2 Receptor Activation in Colospinal Afferent Neurons (CANs) During Inflammation Induced Visceral Hypersensitivity

Overview

Journal Mol Pain

Date 2009 Sep 24

PMID 19772634

Citations 8

Authors

Shelby K Suckow

Robert M Caudle

Affiliations

Soon will be listed here.

Abstract

Background: Visceral hypersensitivity is a clinical observation made when diagnosing patients with functional bowel disorders. The cause of visceral hypersensitivity is unknown but is thought to be attributed to inflammation. Previously we demonstrated that a unique set of enteric neurons, colospinal afferent neurons (CANs), co-localize with the NR1 and NR2D subunits of the NMDA receptor as well as with the PAR2 receptor. The aim of this study was to determine if NMDA and PAR2 receptors expressed on CANs contribute to visceral hypersensitivity following inflammation. Recently, work has suggested that dorsal root ganglion (DRG) neurons expressing the transient receptor potential vanilloid-1 (TRPV1) receptor mediate inflammation induced visceral hypersensitivity. Therefore, in order to study CAN involvement in visceral hypersensitivity, DRG neurons expressing the TRPV1 receptor were lesioned with resiniferatoxin (RTX) prior to inflammation and behavioural testing.

Results: CANs do not express the TRPV1 receptor; therefore, they survive following RTX injection. RTX treatment resulted in a significant decrease in TRPV1 expressing neurons in the colon and immunohistochemical analysis revealed no change in peptide or receptor expression in CANs following RTX lesioning as compared to control data. Behavioral studies determined that both inflamed non-RTX and RTX animals showed a decrease in balloon pressure threshold as compared to controls. Immunohistochemical analysis demonstrated that the NR1 cassettes, N1 and C1, of the NMDA receptor on CANs were up-regulated following inflammation. Furthermore, inflammation resulted in the activation of the PAR2 receptors expressed on CANs.

Conclusion: Our data show that inflammation causes an up-regulation of the NMDA receptor and the activation of the PAR2 receptor expressed on CANs. These changes are associated with a decrease in balloon pressure in response to colorectal distension in non-RTX and RTX lesioned animals. Therefore, these data suggest that CANs contribute to visceral hypersensitivity during inflammation.

Citing Articles

Low-Affinity NMDA Receptor Antagonist Hemantane in a Topical Formulation Attenuates Arthritis Induced by Freund's Complete Adjuvant in Rats.

Ivanova E, Matyushkin A, Sorokina A, Alexeeva S, Miroshkina I, Kachalov K Adv Pharm Bull. 2024; 14(1):241-252.

PMID: 38585463 PMC: 10997923. DOI: 10.34172/apb.2024.002.

Peripheral and Spinal Mechanisms Involved in Electro-Acupuncture Therapy for Visceral Hypersensitivity.

Tahir A, Li J, Tang Y Front Neurosci. 2021; 15:696843.

PMID: 34658755 PMC: 8511820. DOI: 10.3389/fnins.2021.696843.

Electroacupuncture intervention of visceral hypersensitivity is involved in PAR-2-activation and CGRP-release in the spinal cord.

Shah M, Ding Y, Wan J, Janyaro H, Tahir A, Vodyanoy V Sci Rep. 2020; 10(1):11188.

PMID: 32636402 PMC: 7341736. DOI: 10.1038/s41598-020-67702-2.

Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism.

Zhang Y, Ge T, Xiang P, Mao H, Tang S, Li A Drug Des Devel Ther. 2018; 12:2403-2411.

PMID: 30122898 PMC: 6078190. DOI: 10.2147/DDDT.S160628.

Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization.

Mohammadi E, Ligon C, Silos-Santiago A, Ge P, Kurtz C, Higgins C J Pharmacol Exp Ther. 2018; 366(2):274-281.

PMID: 29784661 PMC: 6034264. DOI: 10.1124/jpet.118.248567.

References

Zhai Q, Traub R . The NMDA receptor antagonist MK-801 attenuates c-Fos expression in the lumbosacral spinal cord following repetitive noxious and non-noxious colorectal distention. Pain. 1999; 83(2):321-9. DOI: 10.1016/s0304-3959(99)00116-5. View

Traub R, Murphy A . Colonic inflammation induces fos expression in the thoracolumbar spinal cord increasing activity in the spinoparabrachial pathway. Pain. 2002; 95(1-2):93-102. DOI: 10.1016/s0304-3959(01)00381-5. View

De Schepper H, DE Man J, Van Nassauw L, Timmermans J, Herman A, Pelckmans P . Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. Gut. 2006; 56(2):195-202. PMC: 1856754. DOI: 10.1136/gut.2006.104745. View

Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N . Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut. 2008; 57(9):1222-9. DOI: 10.1136/gut.2008.150722. View

Amadesi S, Nie J, Vergnolle N, Cottrell G, Grady E, Trevisani M . Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci. 2004; 24(18):4300-12. PMC: 6729438. DOI: 10.1523/JNEUROSCI.5679-03.2004. View

Wang G, Tang B, Traub R . Differential processing of noxious colonic input by thoracolumbar and lumbosacral dorsal horn neurons in the rat. J Neurophysiol. 2005; 94(6):3788-94. DOI: 10.1152/jn.00230.2005. View

Zhou Q, Price D, Caudle R, Verne G . Spinal NMDA NR1 subunit expression following transient TNBS colitis. Brain Res. 2009; 1279:109-20. PMC: 2743074. DOI: 10.1016/j.brainres.2009.04.038. View

Zheng X, Zhang L, Durand G, Bennett M, Zukin R . Mutagenesis rescues spermine and Zn2+ potentiation of recombinant NMDA receptors. Neuron. 1994; 12(4):811-8. DOI: 10.1016/0896-6273(94)90334-4. View

Vergnolle N . Protease-activated receptors and inflammatory hyperalgesia. Mem Inst Oswaldo Cruz. 2005; 100 Suppl 1:173-6. DOI: 10.1590/s0074-02762005000900029. View

10.

Vergnolle N, Bunnett N, Sharkey K, Brussee V, Compton S, Grady E . Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med. 2001; 7(7):821-6. DOI: 10.1038/89945. View

11.

De Schepper H, DE Man J, Ruyssers N, Deiteren A, Van Nassauw L, Timmermans J . TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats. Am J Physiol Gastrointest Liver Physiol. 2007; 294(1):G245-53. DOI: 10.1152/ajpgi.00351.2007. View

12.

McRoberts J, Coutinho S, Marvizon J, Grady E, Tognetto M, Sengupta J . Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology. 2001; 120(7):1737-48. DOI: 10.1053/gast.2001.24848. View

13.

Traub R . Evidence for thoracolumbar spinal cord processing of inflammatory, but not acute colonic pain. Neuroreport. 2000; 11(10):2113-6. DOI: 10.1097/00001756-200007140-00011. View

14.

Traub R, Herdegen T, Gebhart G . Differential expression of c-fos and c-jun in two regions of the rat spinal cord following noxious colorectal distention. Neurosci Lett. 1993; 160(2):121-5. DOI: 10.1016/0304-3940(93)90394-z. View

15.

Fang X, Djouhri L, Black J, Dib-Hajj S, Waxman S, Lawson S . The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci. 2002; 22(17):7425-33. PMC: 6757987. View

16.

Steinhoff M, Vergnolle N, Young S, Tognetto M, Amadesi S, Ennes H . Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med. 2000; 6(2):151-8. DOI: 10.1038/72247. View

17.

Vergnolle N . Clinical relevance of proteinase activated receptors (pars) in the gut. Gut. 2005; 54(6):867-74. PMC: 1774539. DOI: 10.1136/gut.2004.048876. View

18.

Coutinho S, Meller S, Gebhart G . Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res. 1996; 736(1-2):7-15. DOI: 10.1016/0006-8993(96)00661-0. View

19.

Nystedt S, Larsson A, Aberg H, Sundelin J . The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem. 1995; 270(11):5950-55. DOI: 10.1074/jbc.270.11.5950. View

20.

Mayer E, Gebhart G . Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994; 107(1):271-93. DOI: 10.1016/0016-5085(94)90086-8. View